Drugs / AB-2004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04895215 | Aug 2021 → Nov 2023 | autism spectrum disorder | Vertero Therapeutics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AB-2004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04895215 ↗ |